Business Description
Medimaging Integrated Solution Inc
ISIN : TW0006796006
Total Employee Number:
109Description
Medimaging Integrated Solution Inc and its subsidiaries are engaged in the design, manufacturing, and sales of digital medical imaging diagnostic equipment and related products and services. The company is a trusted partner of hospitals, medical schools, and health organizations, providing practitioners with digital and portable diagnostic solutions. The company designs and manufactures digital hand-held diagnostic scopes. Its products include Horus Scope, Smart Solutions, Endoscopy, and Micro Camera Modules.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.81 | |||||
Equity-to-Asset | 0.47 | |||||
Debt-to-Equity | 0.9 | |||||
Debt-to-EBITDA | 8.15 | |||||
Interest Coverage | 1.83 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.69 | |||||
Beneish M-Score | -2.4 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.5 | |||||
3-Year EBITDA Growth Rate | -13.1 | |||||
3-Year EPS without NRI Growth Rate | -48.7 | |||||
3-Year Book Growth Rate | 4 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 57.94 | |||||
9-Day RSI | 52.25 | |||||
14-Day RSI | 47.78 | |||||
3-1 Month Momentum % | -14.33 | |||||
6-1 Month Momentum % | -34.27 | |||||
12-1 Month Momentum % | -15.85 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.26 | |||||
Quick Ratio | 1.72 | |||||
Cash Ratio | 1.2 | |||||
Days Inventory | 205.35 | |||||
Days Sales Outstanding | 78.35 | |||||
Days Payable | 30.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.83 | |||||
Dividend Payout Ratio | 1.83 | |||||
3-Year Dividend Growth Rate | -29.8 | |||||
Forward Dividend Yield % | 0.42 | |||||
5-Year Yield-on-Cost % | 0.81 | |||||
3-Year Average Share Buyback Ratio | -0.8 | |||||
Shareholder Yield % | -2.28 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 42.31 | |||||
Operating Margin % | 3.15 | |||||
Net Margin % | 1.17 | |||||
EBITDA Margin % | 12.49 | |||||
FCF Margin % | -8.05 | |||||
OCF Margin % | -2.44 | |||||
ROE % | 1.07 | |||||
ROA % | 0.56 | |||||
ROIC % | 1.27 | |||||
3-Year ROIIC % | -7.37 | |||||
ROC (Joel Greenblatt) % | 3.63 | |||||
ROCE % | 2.43 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 285.72 | |||||
PE Ratio without NRI | 214.82 | |||||
PS Ratio | 3.3 | |||||
PB Ratio | 2.97 | |||||
Price-to-Tangible-Book | 3.09 | |||||
EV-to-EBIT | 96.34 | |||||
EV-to-EBITDA | 30.36 | |||||
EV-to-Revenue | 3.79 | |||||
EV-to-FCF | -48.08 | |||||
Price-to-GF-Value | 0.55 | |||||
Price-to-Graham-Number | 5.43 | |||||
| Price-to-Net-Current-Asset-Value | 11.01 | |||||
Earnings Yield (Greenblatt) % | 1.04 | |||||
FCF Yield % | -2.24 | |||||
Forward Rate of Return (Yacktman) % | -9.56 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medimaging Integrated Solution Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 661.389 | ||
| EPS (TTM) (NT$) | 0.203 | ||
| Beta | 0.6814 | ||
| 3-Year Sharpe Ratio | -0.68 | ||
| 3-Year Sortino Ratio | -0.97 | ||
| Volatility % | 35.5 | ||
| 14-Day RSI | 47.78 | ||
| 14-Day ATR (NT$) | 2.038402 | ||
| 20-Day SMA (NT$) | 58.665 | ||
| 12-1 Month Momentum % | -15.85 | ||
| 52-Week Range (NT$) | 55.6 - 104.973107 | ||
| Shares Outstanding (Mil) | 40.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medimaging Integrated Solution Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medimaging Integrated Solution Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 0.250000 Cash Dividend | 2026-07-24 | In 17 days | ||
| TWD 0.492831 Cash Dividend | 2025-08-19 | 72.22 (-1.10%) | ||
| 1.1:1 Stock Split | 2025-08-19 | 72.22 (-1.10%) | ||
| TWD 1.609692 Cash Dividend | 2024-07-19 | 89.61 (-0.99%) | ||
| 1.276:1 Stock Split | 2021-07-29 | 57.73 (-0.82%) |
Show
Entries
Medimaging Integrated Solution Inc Frequently Asked Questions
What is Medimaging Integrated Solution Inc(TPE:6796)'s stock price today?
The current price of TPE:6796 is NT$58.00. The 52 week high of TPE:6796 is NT$104.97 and 52 week low is NT$55.60.
When is next earnings date of Medimaging Integrated Solution Inc(TPE:6796)?
The next earnings date of Medimaging Integrated Solution Inc(TPE:6796) is .
Does Medimaging Integrated Solution Inc(TPE:6796) pay dividends? If so, how much?
The Dividend Yield %  of Medimaging Integrated Solution Inc(TPE:6796) is 0.83% (As of Today), Highest Dividend Payout Ratio of Medimaging Integrated Solution Inc(TPE:6796) was 8.99. The lowest was 0.7. And the median was 0.81. The  Forward Dividend Yield % of Medimaging Integrated Solution Inc(TPE:6796) is 0.42%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Medimaging Integrated Solution Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers